Publishing 72 Papers a Year: What Hyperprolific Authorship Means for Medical Research Integrity in 2026

Seventy-two papers in a calendar year. That works out to roughly one article every five working days, or about four hours of exclusive attention per paper if a researcher does nothing else all year. No conferences, no clinical work, no grant writing, no teaching, no holidays. For most medical researchers who have been through the full cycle of a single paper, that number is immediately recognizable as impossible unless something is being done that probably should not be.

That threshold, established in a 2019 PLoS Biology analysis by Ioannidis and Baas, became the working definition of a “hyperprolific author.” Seven years later, the problem has not shrunk. A 2026 Scientometrics paper titled “The complex ecosystem of hyperprolific authors” estimated that over 9,000 researchers worldwide met the 72-paper threshold in at least one year between 2019 and 2024. At a more conservative 40-paper-per-year threshold, the number of qualifying researchers grew by 66 percent between 2019 and 2023, a period when overall publication output rose only around 15 percent. The output is rising faster than the field.

A separate 2026 PLOS One study examined hyperprolific authorship specifically within sports medicine and musculoskeletal health research, analyzing publications from the top 20 CiteScore-ranked journals in that specialty between 2020 and 2024. A concurrent Research Integrity and Peer Review article from Springer Nature described the same patterns across disciplines under the heading of “strategic co-authorship.” The framing is slightly different in each paper, but the underlying observation is the same: a meaningful fraction of academic authorship in medicine reflects social or institutional arrangements rather than genuine intellectual contribution, and the incentive structures that produced this are not going away on their own.

What the ICMJE Authorship Criteria Actually Require

The International Committee of Medical Journal Editors has maintained four authorship criteria since 2013, and all four must be met for a person to qualify as an author. The criteria are well known in principle but rarely rehearsed in practice by research teams deciding who goes on the byline.

The first criterion is substantial contribution to conception or design, or to the acquisition, analysis, or interpretation of data. The second is drafting the work or revising it critically for important intellectual content. The third is final approval of the version to be published. The fourth is accountability for all aspects of the work, including the integrity of any part. That last one is not merely a formality. It means every author should be able to answer questions about any finding in the paper, not just their own section. In a study with 40 co-authors, that accountability is implausible for most of them, and the ICMJE language does not suggest it is optional.

Individuals who contribute only data collection, funding acquisition, departmental oversight, or general administrative support do not qualify for authorship under these criteria. They belong in the acknowledgements. That distinction is not enforced by any universal mechanism at medical journals, but it is the stated standard of every major publishing body including COPE, WAME, and the publishing policies of Elsevier, Springer Nature, Wiley, and BMJ.

Survey studies have tested compliance with these criteria by asking authors directly. The results are uncomfortable. A widely cited survey found that somewhere between 18 and 57 percent of authors on biomedical papers do not meet all four ICMJE criteria, depending on the specific study and field. A separate survey focused on researchers who had produced hyperprolific output found that around 70 percent admitted not fulfilling the full ICMJE criteria on more than a quarter of their listed papers. Whether respondents answered honestly or strategically in those surveys is impossible to know, but the scale of acknowledged non-compliance suggests the problem is not marginal.

Why Cardiology Is the Most Affected Medical Field

Of all medical specialties, cardiology has emerged as the one with the greatest concentration of hyperprolific authors. A 2025 analysis identified 137 individuals in cardiology alone who met the 72-paper annual threshold repeatedly, a number that is considerably higher than any other non-physics discipline. A Research Integrity analysis specifically asked why this pattern concentrates in cardiology, and several structural explanations converge.

Cardiology produces large amounts of registry and database research. A single large database, such as a national cardiac registry, a claims database, or a multi-site electronic health record system, can be mined repeatedly by different authors asking modestly different questions. The same senior investigator who controls or is associated with that database can appear as a co-author on dozens of papers annually, each of which represents a genuinely small research act by the named team, with the senior author contributing primarily access or institutional cover. This is not fabrication in the traditional sense. But when the same name appears on 80 papers in a year, it is worth asking how thoroughly that person engaged with each one.

The same pattern appears in fields with large international consortium studies, where a steering committee member or principal investigator may be listed on every output from a multi-center collaboration. The ICMJE criteria do not prohibit appearing on many papers if genuine contribution is made to each. But they do set a standard that is almost certainly not met when the output volume reaches several papers per month. Sports medicine, musculoskeletal research, and several areas of oncology show similar patterns, and the 2026 studies suggest those fields are catching up to cardiology in rate of growth.

Physics, by contrast, has long had hyperprolific authorships as a structural feature of high-energy physics, where experimental consortia of thousands of researchers list all participants as authors on every paper. The CERN collaboration papers are the most extreme example. Most analysts treat physics as a distinct case rather than an integrity concern, because the authorship conventions are explicit, explained in the paper, and understood by readers in the field.

The Mechanisms Behind Impossible Output

Understanding why someone ends up on 80 papers in a year requires distinguishing between several different practices, not all of which carry the same ethical weight. The most serious involve what COPE classifies as gift authorship and ghost authorship. Gift authorship means including someone as an author because of their seniority, institutional power, funding, or prestige, rather than their actual contribution. Ghost authorship means excluding from the byline someone who did substantial work, such as a medical writer hired by a pharmaceutical company. Both are violations of ICMJE criteria, and both are considered research misconduct under COPE guidance.

A subtler variant involves what the 2026 Research Integrity and Peer Review paper calls strategic co-authorship. This covers reciprocal authorship arrangements where researchers in a network systematically add each other to papers, rotating the contribution requirements enough to maintain plausible deniability but not enough to meet the full ICMJE standard. It also covers departmental norms where a senior faculty member or department chair expects to be listed on everything produced in their unit, regardless of whether they reviewed the work. In some institutional cultures, omitting the department head from a paper is understood as professionally risky, and junior researchers comply not because the head contributed but because they feel they cannot refuse.

A third mechanism is database or consortium inflation. A researcher who has spent years building a national registry or securing access to a large multi-site dataset occupies a genuine and often underappreciated role in enabling the science that follows. But the convention of including that researcher as a named author on every paper that uses the dataset, rather than in the acknowledgements as a data custodian, is not technically justified by the ICMJE criteria. The distinction matters because authorship carries accountability, and accountability for 70 papers a year is not a meaningful promise.

AI-assisted writing has added a new layer to this problem. As submission volumes rise with the help of writing tools, the practical constraint of actually producing a manuscript has lessened for research teams where ideas and data are abundant but writing capacity is the bottleneck. This makes it easier to produce more papers, and easier to include more names on each one without the check that used to come from everyone having to spend real time on the manuscript.

Self-Citation Rings and Metric Distortion

Hyperprolific authors do not just inflate the byline. They tend to appear in interlocking networks where the same set of researchers cite each other repeatedly. The 2026 Scientometrics analysis described this as a feature of the hyperprolific ecosystem: researchers who produce at extreme rates are significantly more likely to be highly cited, not because their papers are unusually influential but because citation tends to cluster within the same collaborative network. A paper from group A cites papers from group B, and group B's papers cite group A, producing elevated citation counts that read as impact but actually reflect social structure.

This has practical consequences for journal selection. If a journal's impact factor is supported substantially by citation activity from a small network of hyperprolific authors who cite each other's work, the metric reflects those relationships more than it reflects how widely read the journal is in the broader community. Authors selecting a target journal based on impact factor are not usually in a position to audit that distinction, but it is a known phenomenon in bibliometrics and one of the reasons COPE has flagged self-citation rings as a form of editorial misconduct when journals encourage them.

What Journals and Publishers Are Doing About It

The response from journals and publishers has been slow relative to the scale of the problem, but it is growing. Several changes are now visible.

The CRediT taxonomy, now mandatory at most major publishers including Elsevier, Springer Nature, and BMJ, requires authors to assign formal roles to each contributor using 14 standardized categories ranging from Conceptualization and Formal Analysis to Writing (original draft) and Writing (review and editing). In principle, CRediT should make it easier to spot when a senior author is listed with only Supervision or Funding acquisition credit, which alone would not satisfy ICMJE criteria. In practice, CRediT statements are often filled in hastily or collectively, and journals do not typically audit them. Still, the data is there in the published record, and it creates documentary evidence if a post-publication integrity concern ever arises.

Some publishers have begun building automated flags into their editorial management systems that alert editors when a submitting author appears as a named author on an unusually high number of recently submitted or published manuscripts across the publisher's journal portfolio. Springer Nature and Wiley have both referenced such systems in public integrity discussions, though neither has published precise thresholds or detailed detection methodologies. The practical deterrent effect is uncertain, but the signals exist and are being used.

A smaller number of journals have gone further. The British Journal of Sports Medicine and several sports medicine titles that feed into the PLOS One dataset mentioned in the 2026 study have updated their authorship policies to include explicit language about the implausibility of contributing meaningfully to more than a defined number of papers in a given period. The language tends to be hedged because no threshold is legally defensible, but the stated intent is to put authors on notice that extreme output will attract scrutiny.

What This Means If Your Paper Has a Hyperprolific Co-Author

Not every researcher with high output is engaged in misconduct. Some are genuinely prolific through large collaborative networks, efficient research teams, or fields with fast publication cycles. The concern is not with productivity itself. The concern is with authorship that does not reflect real contribution, because that authorship carries accountability that is then left unmet.

If your paper includes a senior co-author whose name appears on dozens of papers per year, there are practical steps worth taking before submission. First, confirm that person has actually reviewed a complete version of the manuscript and approved the final text. This sounds obvious, but in teams where the senior author is listed as a matter of convention, their review is sometimes nominal. Second, fill in the CRediT contribution statement honestly. If the senior author's only genuine contribution is Supervision or Funding acquisition, note that, and consider whether to add them as a named contributor in the acknowledgements rather than a formal author. Third, if a reviewer or editor challenges the authorship roster after submission, the ability to document each author's specific contribution is your primary line of defense.

The risk extends beyond ethical discomfort. Papers that have faced post-publication integrity scrutiny for authorship reasons typically face prolonged delays in the form of expressions of concern, institutional investigations, and sometimes retractions that reflect not on the data quality but on the process. Corresponding authors bear most of this institutional and reputational exposure, and in most cases, the corresponding author is not the senior researcher whose presence on the paper raised the original question.

Protecting Your Own Authorship Practice

For most working medical researchers, the practical exposure here is not being labeled hyperprolific. It is being in a situation where authorship norms in the local environment diverge from what journals actually require, and finding out about that gap at a bad moment.

The ICMJE criteria are worth reading in full at least once, not just in summary. The key sentence that most researchers miss is the fourth criterion: each author must agree to be accountable for all aspects of the work, in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Not their part. All aspects. If that standard would be embarrassing to apply to someone on your author list, it is worth having a direct conversation before the paper goes out rather than after.

Research teams that establish authorship criteria at the project start, not at the manuscript stage, consistently have fewer disputes and cleaner contribution records. This does not require a formal protocol. It requires one direct conversation early on about who will be listed as an author, what each person will contribute, and who will review the full final manuscript before submission. That conversation can also clarify the acknowledgements section, which exists precisely to credit people whose contributions were real and valued but did not meet the authorship threshold.

The CRediT taxonomy, whatever its limitations as an enforcement mechanism, functions as a useful prompt for this conversation. Filling in the statement accurately forces the team to articulate what each person actually did. If that exercise reveals that someone on the author list contributed only in ways that belong in the acknowledgements, it is better to address that before submission than to leave a CRediT entry that a reviewer or post-publication commentator might later challenge.

Where This Leaves the Reader of Medical Literature

There is one more dimension to this that tends to get less attention than the integrity concerns for authors. If a significant fraction of authorship in medical journals does not represent genuine intellectual accountability, the practical consequence is that the scientific record contains papers whose named authors cannot fully answer for their conclusions. When a paper is challenged, retracted, or corrected, the correspondence should involve the authors who know the data. If those authors were added for social or institutional reasons, they are neither equipped to defend the work nor incentivized to engage with the challenge.

This is part of why the ICMJE language on accountability has become more pointed in recent years, culminating in the explicit 2026 recommendation that authorship and accountability are inseparable. The stated aim is not to catch bad actors, though that is a side effect. The aim is to make the scientific record more reliable by ensuring that each paper has at least some authors who are genuinely responsible for it.

For readers of medical research, the practical takeaway is modest but useful. An unusually long author list on a paper is not automatically a red flag. But it is a reason to pay closer attention to the CRediT statement if one is present, to check whether the methodology section reads as though it was written by someone who understood it, and to note whether the corresponding author has a publication record that suggests genuine engagement with this type of work. None of that is a substitute for the peer review process, which remains the primary quality check, but hyperprolific authorship is one of the places where that process is most likely to have been stretched.

Further Reading